In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers

Urolithiasis ◽  
2015 ◽  
Vol 43 (2) ◽  
pp. 125-134 ◽  
Author(s):  
Pajaree Chariyavilaskul ◽  
Poonsin Poungpairoj ◽  
Suchada Chaisawadi ◽  
Chanchai Boonla ◽  
Thasinas Dissayabutra ◽  
...  
2018 ◽  
Vol 132 (6) ◽  
pp. 615-626 ◽  
Author(s):  
Asokan Devarajan

The prevalence of kidney stones and cardiovascular diseases (CVDs) are increasing throughout the world. Both diseases are chronic and characterized by accumulation of oxidized proteins and lipids in the renal tissue and arterial wall, respectively. Emerging studies have revealed a positive association between nephrolithiasis and CVDs. Based on preclinical and clinical evidences, this review discusses: (i) stone forming risk factors, crystal nucleation, aggregation, injury-induced crystal retention, and stone formation, (ii) CVD risk factors such as dyslipidemia, perturbation of gut microbiome, obesity, free radical-induced lipoprotein oxidation, and retention in the arterial wall, subsequent foam cell formation, and atherosclerosis, (iii) mechanism by which stone forming risk factors such as oxalate, calcium, uric acid, and infection contribute toward CVDs, and (iv) how CVD risk factors, such as cholesterol, phospholipids, and uric acid, contribute to kidney stone formation are described.


2019 ◽  
Vol 7 ◽  
Author(s):  
Andrew L. Schwaderer ◽  
Rupesh Raina ◽  
Anshika Khare ◽  
Fayez Safadi ◽  
Sharon M. Moe ◽  
...  

2012 ◽  
Vol 11 (1) ◽  
pp. e856-e856a
Author(s):  
A. Okada ◽  
K. Taguchi ◽  
Y. Hirose ◽  
K. Niimi ◽  
Y. Fujii ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Rejane Barbosa de Oliveira ◽  
Eduardo Barbosa Coelho ◽  
Marina Rezende Rodrigues ◽  
Ana Rita de Mello Costa-Machado ◽  
João Paulo Barreto de Sousa ◽  
...  

The potential of theCopaifera langsdorffiileaves extract to prevent stone formation was analyzed by means of an ethylene glycol (EG) animal model of nephrolithiasis and anin vitrocrystallization assay. Different doses of theC. langsdorffiileaves extract were administered to rats treated with EG. Urine biochemical parameters were quantified. CaOx deposits count and analysis of osteopontin expression were conducted on kidneys fixed in formalin. Thein vitroassay was performed by turbidimetry. Phytochemical analyses of the extract were accomplished by HPLC-UV-DAD, and several compounds were isolated.C. langsdorffiileaf extract was able to avoid stone formation. The number of deposits was50.30±31.29at the higher extract dose, compared to the value of179.5±45.96achieved with the EG control. Significantly lower oxalate levels and OPN expression and increased citrate levels were observed after extract administration. In thein vitroassay, the extract diluted the formed crystals. Phytochemical analyses showed that the extract is rich in phenolic compounds that are capable of preventing stone formation. Thus, on the basis of our results, we suggest that theC. langsdorffiileaf extract has potential application in the prevention of kidney stone formation.


2000 ◽  
Vol 98 (4) ◽  
pp. 471-480 ◽  
Author(s):  
Caroline DEAN ◽  
Jerry KANELLOS ◽  
Hung PHAM ◽  
Maria GOMES ◽  
Adrian OATES ◽  
...  

The bikunin peptide chain of the protease inhibitor inter-α-inhibitor (∣α∣) has been reported to be an inhibitor of calcium oxalate (CaOx) crystallization, and hence has been proposed as having a role in CaOx kidney stone formation. However, further experimental evidence is required to assess if fragments of ∣α∣ other than bikunin may play a role in the regulation of crystallization events in stone formation. The aim of the present study was to assess the effects of ∣α∣ and several of its derivatives on CaOx crystallization in a seeded inorganic system and to compare these effects with those of a known inhibitor of crystallization, prothrombin. ∣α∣ was purified from a preparation of human plasma and fragmented by alkaline hydrolysis, and two of its peptide chains, bikunin and heavy chain 1 (H1), were purified further by HPLC. Their purity was confirmed by SDS/PAGE. Using Coulter counter and [14C]oxalate analysis and scanning electron microscopy, ∣α∣, its H1 chain and bikunin from urine and from plasma were shown to be relatively weak inhibitors of CaOx crystallization in vitro at expected physiological concentrations. It was concluded that members of the ∣α∣ family may not be as important in kidney stone formation as has been generally proposed, although further studies are required before a possible role for ∣α∣ and its fragments in stone formation can be unambiguously discounted.


Sign in / Sign up

Export Citation Format

Share Document